Skip to content
value.today

Who owns Solid Biosciences Inc.?

The parent company, the largest shareholders that report their holdings, the funds that own Solid Biosciences Inc. and what its insiders traded, each from the filing that states it.

The short answer

Solid Biosciences Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders.

158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026.

The largest of them was Ra Capital Management, L.P. with 10.78%, followed by Perceptive Advisors LLC (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%).

128 mutual funds held 21.2% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's.

In the last 12 months its insiders reported no purchases and 28 sales worth $3 M on SEC Form 4.

Newest figure: Sep 30, 2026.

Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 158 holders, 106.5% of the shares together.

Largest institutional shareholders of Solid Biosciences Inc.
#HolderOf the sharesValueSharesChange in the quarter
1Ra Capital Management, L.P.10.78%$87 M12.0 M0.0%
2Perceptive Advisors LLC10.67%$86 M11.9 M0.0%
3Bain Capital Life Sciences Investors, LLC8.79%$71 M9.8 M0.0%
4Siren, L.L.C.6.89%$56 M7.7 M0.0%
5FMR LLC6.52%$53 M7.3 M+5.8%
6BlackRock, Inc.6.12%$49 M6.8 M-1.4%
7RTW Investments, LP5.29%$43 M5.9 M+51.7%
8Armistice Capital, LLC4.03%$33 M4.5 M+5.1%
9Franklin Templeton Inc3.76%$30 M4.2 M+21.9%
10Vanguard Capital Management LLC3.56%$29 M4.0 M-1.1%

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Filings read up to Nov 17, 2026; the quarter is still being filed (99% of last quarter's holders so far). People who hold shares in their own name, such as founders, are not in 13F reports

How ownership moved#

Institutions held 106.5% of Solid Biosciences Inc. at Sep 30, 2026, down 0.28 points from Jun 30, 2026; 2 more institutions.

Institutional ownership of Solid Biosciences Inc. by quarter
Quarter endInstitutionsShare of the companyShares boughtShares soldPositions openedPositions closed
Sep 30, 2026(still being filed)158106.5%10.7 M3.5 M2525
Jun 30, 2026156106.8%24.7 M7.7 M40—
Mar 31, 2026141101.5%————
Dec 31, 202512382.7%————
Sep 30, 2025120104.5%————
Jun 30, 2025110105.6%————
Mar 31, 2025122101.8%————
Dec 31, 20248946.9%————
Sep 30, 20249189.7%————
Jun 30, 20247997.4%————
Mar 31, 20245392.7%————
Dec 31, 20233744.0%————
Sep 30, 20233580.1%————
Jun 30, 20233481.5%————
Mar 31, 20233780.6%————
Dec 31, 20223378.2%————

Bought most, quarter to Sep 30, 2026

  1. RTW Investments, LP+2.0 M
  2. Jpmorgan Chase & Co+899,757
  3. Morgan Stanley+898,323
  4. Qube Research & Technologies Ltd+880,714
  5. Franklin Templeton Inc+752,789
  6. Ameriprise Financial Inc+692,997
  7. FMR LLC+397,412
  8. Charles Schwab Investment Management Inc+369,100

Sold most

  1. State Street Corp−852,300
  2. Citadel Advisors LLC−717,917
  3. Goldman Sachs Group Inc−445,087
  4. Point72 Asset Management, L.P.−347,537
  5. Algert Global LLC−111,849
  6. D. E. Shaw & Co., Inc.−106,793
  7. BlackRock, Inc.−99,004
  8. Monashee Investment Management LLC−90,000

New positions (shares held)

  1. Ghisallo Capital Management LLC500,000
  2. Affinity Asset Advisors, LLC400,000
  3. Millennium Management LLC237,633
  4. HRT Financial LP118,384
  5. Squarepoint Ops LLC105,624
  6. Weiss Asset Management LP93,052
  7. Aquatic Capital Management LLC90,954
  8. Optimize Financial Inc.46,991

Insiders' open-market purchases (up) and sales (down), by quarter

Source: SEC Form 13F data sets and Forms 4 and 5. Institutions report three months after each quarter; a quarter's purchases and sales add up each institution's change since its report for the quarter before. Insiders' trades count open-market purchases and sales only, in the company's reporting currency. 131 mutual funds and ETFs hold Solid Biosciences Inc. in their latest reports: 24 new, 76 adding, 31 cutting.

128 funds held 21.2% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.

Largest fund holders of Solid Biosciences Inc.
FundManagerCountryOf the companyValueReport of
Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.🇺🇸2.82%$31 MJun 30, 2026
State Street SPDR S&P Biotech ETFSSGA Funds Management, Inc.🇺🇸2.31%$26 MJun 30, 2026
iShares Russell 2000 ETFBlackRock Fund Advisors🇺🇸1.84%$21 MJun 30, 2026
Select Biotechnology PortfolioFidelity Management & Research Company LLC🇺🇸2.34%$19 MMay 31, 2026
Franklin Biotechnology Discovery FundFranklin Advisers, Inc.🇺🇸1.26%$11 MJul 31, 2026

Source: Fund portfolios filed with regulators (SEC Form N-PORT and others) · as of Jul 31, 2026

Purchases
0
Sales
28
Bought
$0 M
Sold
$3 M

Source: SEC Forms 4 and 5, open-market purchases and sales

Questions and answers#

Who owns Solid Biosciences Inc.?

Solid Biosciences Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders. 158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026. The largest of them was Ra Capital Management, L.P. with 10.78%, followed by Perceptive Advisors LLC (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%).

Who is the largest shareholder of Solid Biosciences Inc.?

Among investors that file SEC Form 13F, Ra Capital Management, L.P. was the largest on Sep 30, 2026, with 10.78% of the shares. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.

How much of Solid Biosciences Inc. do institutional investors own?

158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026.

Which mutual funds own Solid Biosciences Inc.?

128 mutual funds held 21.2% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.

Sources#

Every figure on this page comes from these, with the date shown next to it.

Definitions on the methodology page.

More about Solid Biosciences Inc.#

Something wrong or missing about Solid Biosciences Inc. (who owns it)? Suggest a correction